Event to be Webcast Live on the MediaAlpha Investor Relations WebsiteLOS ANGELES, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- MediaAlpha, Inc. (NYSE: MAX), today announced that it will release third quarter 2025 financial results on Wednesday, October 29, 2025 after market close. The company will host a Q&A conference call to discuss these results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. A live webcast of the call will be available on MediaAlpha’s Investor Relations website at https ...

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, has announced plans to expand its medical cannabis operations into Panama. In connection with its expansion into Panama, Tilray has entered into a joint venture with Top Tech Glo ...

SAN FRANCISCO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today announced that it will release its financial results for the third quarter, ended September 30, 2025, after the market closes on November 10, 2025. The RealReal will host a conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to review its financial results. A live webcast of the conference call will be available online at investor.the ...

Presentations feature data from first-in-human Phase 1 study including Cyclin E1 biomarker findings, supporting late-stage development of azenosertibSAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that four azenosertib abstracts have been accepted for poster presentation at the AACR-NCI-EORTC Int ...

Steven Tahmooressi to lead global marketing efforts for GraftAssure family of assays and future productsBrings 25 years of experience driving new product adoption across geographies in transplantation, oncology and immunology NASHVILLE, Tenn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it has welcomed Steven Tahmooressi to its executive leadership team as the company prepares to launch its first clinical kitted assay in 2026. As Vice P ...

RUTLAND, Vt., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Casella Waste Systems, Inc. (Nasdaq: CWST), a regional solid waste, recycling, and resource management services company, will release its financial results for the three months ended September 30, 2025, after the market closes on Thursday, October 30, 2025. The company will host a conference call to discuss these results on Friday, October 31, 2025, at 10:00 a.m. Eastern Time. Individuals interested in participating in the call should register by clicking here ...

Shelton, CT, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) today announced it will release its third quarter 2025 financial results prior to the opening of the market on October 28th, 2025. The Company will then webcast its Analysts' Conference Call to discuss the results at 10:00 AM ET. The full text of the press release announcing the results will be posted on Hubbell's corporate website under the Press Release section. You can also access this information by going to www.hubbell.co ...

PEMBROKE, Bermuda, Oct. 13, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) will release third quarter earnings after the market closes on Monday November 3, 2025. It will also host an earnings conference call on Tuesday, November 4, 2025 beginning at 9:00 a.m. (Eastern Time). The conference call may be accessed by dialing (800) 715-9871, conference ID 6910670, or via the investor website at https://investors.jrvrgroup.com. A replay will also be avai ...

Translational data validate mechanism of first-in-concept extracellular-cleaving ADC micvotabart pelidotin (MICVO) MICVO combats solid tumors through three-pronged mechanism of action: direct tumor cell killing, bystander effect, and immunogenic cell death Findings demonstrate MICVO’s effects on tumor microenvironment remodeling and immune activation Translational data to be presented in two posters at ESMO 2025 and six posters at AACR-NCI-EORTC BOSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. ...

SAN JOSE, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) will announce its financial results for the third quarter ended September 30, 2025, on Monday, November 3, 2025. The company will host an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) that same day. To access the earnings conference call: U.S. callers, please dial +1 (888) 660-6411International callers, please dial +1 (929) 203-0849 All participants should dial in 15 minutes prior to the start of the ...